These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15833860)

  • 1. Cortactin overexpression inhibits ligand-induced down-regulation of the epidermal growth factor receptor.
    Timpson P; Lynch DK; Schramek D; Walker F; Daly RJ
    Cancer Res; 2005 Apr; 65(8):3273-80. PubMed ID: 15833860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant expression of cortactin in head and neck squamous cell carcinoma cells is associated with enhanced cell proliferation and resistance to the epidermal growth factor receptor inhibitor gefitinib.
    Timpson P; Wilson AS; Lehrbach GM; Sutherland RL; Musgrove EA; Daly RJ
    Cancer Res; 2007 Oct; 67(19):9304-14. PubMed ID: 17909038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Src promotes destruction of c-Cbl: implications for oncogenic synergy between Src and growth factor receptors.
    Bao J; Gur G; Yarden Y
    Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2438-43. PubMed ID: 12604776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cbl and Itch binding sites in ERBB4 CYT-1 and CYT-2 mediate K48- and K63-polyubiquitination, respectively.
    Meijer IM; van Rotterdam W; van Zoelen EJ; van Leeuwen JE
    Cell Signal; 2013 Feb; 25(2):470-8. PubMed ID: 23153581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor receptors with tyrosine kinase domain mutations exhibit reduced Cbl association, poor ubiquitylation, and down-regulation but are efficiently internalized.
    Padrón D; Sato M; Shay JW; Gazdar AF; Minna JD; Roth MG
    Cancer Res; 2007 Aug; 67(16):7695-702. PubMed ID: 17699773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serine mutations that abrogate ligand-induced ubiquitination and internalization of the EGF receptor do not affect c-Cbl association with the receptor.
    Oksvold MP; Thien CB; Widerberg J; Chantry A; Huitfeldt HS; Langdon WY
    Oncogene; 2003 Nov; 22(52):8509-18. PubMed ID: 14627991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cbl-mediated ubiquitinylation is required for lysosomal sorting of epidermal growth factor receptor but is dispensable for endocytosis.
    Duan L; Miura Y; Dimri M; Majumder B; Dodge IL; Reddi AL; Ghosh A; Fernandes N; Zhou P; Mullane-Robinson K; Rao N; Donoghue S; Rogers RA; Bowtell D; Naramura M; Gu H; Band V; Band H
    J Biol Chem; 2003 Aug; 278(31):28950-60. PubMed ID: 12754251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortactin overexpression regulates actin-related protein 2/3 complex activity, motility, and invasion in carcinomas with chromosome 11q13 amplification.
    Rothschild BL; Shim AH; Ammer AG; Kelley LC; Irby KB; Head JA; Chen L; Varella-Garcia M; Sacks PG; Frederick B; Raben D; Weed SA
    Cancer Res; 2006 Aug; 66(16):8017-25. PubMed ID: 16912177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mutant EGF-receptor defective in ubiquitylation and endocytosis unveils a role for Grb2 in negative signaling.
    Waterman H; Katz M; Rubin C; Shtiegman K; Lavi S; Elson A; Jovin T; Yarden Y
    EMBO J; 2002 Feb; 21(3):303-13. PubMed ID: 11823423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herpes simplex virus 1 infected cell protein 0 forms a complex with CIN85 and Cbl and mediates the degradation of EGF receptor from cell surfaces.
    Liang Y; Kurakin A; Roizman B
    Proc Natl Acad Sci U S A; 2005 Apr; 102(16):5838-43. PubMed ID: 15824310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of cortactin in head and neck squamous cell carcinomas can be uncoupled from augmented EGF receptor expression.
    Fantozzi I; Grall D; Cagnol S; Stanchi F; Sudaka A; Brunstein MC; Bozec A; Fischel JL; Milano G; Van Obberghen-Schilling E
    Acta Oncol; 2008; 47(8):1502-12. PubMed ID: 18607838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association with HSP90 inhibits Cbl-mediated down-regulation of mutant epidermal growth factor receptors.
    Yang S; Qu S; Perez-Tores M; Sawai A; Rosen N; Solit DB; Arteaga CL
    Cancer Res; 2006 Jul; 66(14):6990-7. PubMed ID: 16849543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation.
    Gur G; Rubin C; Katz M; Amit I; Citri A; Nilsson J; Amariglio N; Henriksson R; Rechavi G; Hedman H; Wides R; Yarden Y
    EMBO J; 2004 Aug; 23(16):3270-81. PubMed ID: 15282549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TULA: an SH3- and UBA-containing protein that binds to c-Cbl and ubiquitin.
    Feshchenko EA; Smirnova EV; Swaminathan G; Teckchandani AM; Agrawal R; Band H; Zhang X; Annan RS; Carr SA; Tsygankov AY
    Oncogene; 2004 Jun; 23(27):4690-706. PubMed ID: 15107835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct interaction of Cbl with pTyr 1045 of the EGF receptor (EGFR) is required to sort the EGFR to lysosomes for degradation.
    Grøvdal LM; Stang E; Sorkin A; Madshus IH
    Exp Cell Res; 2004 Nov; 300(2):388-95. PubMed ID: 15475003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortactin is a substrate of activated Cdc42-associated kinase 1 (ACK1) during ligand-induced epidermal growth factor receptor downregulation.
    Kelley LC; Weed SA
    PLoS One; 2012; 7(8):e44363. PubMed ID: 22952966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas.
    Li B; Chang CM; Yuan M; McKenna WG; Shu HK
    Cancer Res; 2003 Nov; 63(21):7443-50. PubMed ID: 14612544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of epidermal growth factor receptor induces sequestration of extracellular signal-related kinases and selective attenuation of specific epidermal growth factor-mediated signal transduction pathways.
    Habib AA; Chun SJ; Neel BG; Vartanian T
    Mol Cancer Res; 2003 Jan; 1(3):219-33. PubMed ID: 12556561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.
    Gan Y; Shi C; Inge L; Hibner M; Balducci J; Huang Y
    Oncogene; 2010 Sep; 29(35):4947-58. PubMed ID: 20562913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intersectin regulates epidermal growth factor receptor endocytosis, ubiquitylation, and signaling.
    Martin NP; Mohney RP; Dunn S; Das M; Scappini E; O'Bryan JP
    Mol Pharmacol; 2006 Nov; 70(5):1643-53. PubMed ID: 16914641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.